(Q37025655)

17 August 2017

1 reference

title

Clinical applications and availability of CD4+ T cell count testing in sub-Saharan Africa (English)

1 reference

17 August 2017

0 references

Robert L Murphy

2

0 references

author name string

Babafemi O Taiwo

series ordinal

1

1 reference

17 August 2017

publication date

1 January 2008

1 reference

Cytometry Part B: Clinical Cytometry

17 August 2017

published in

1 reference

17 August 2017

volume

74 Suppl 1

1 reference

17 August 2017

page(s)

S11-8

1 reference

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

Determination of T-lymphocyte subsets in a north African population (Tunisia): establishment of normal ranges and results in HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

T lymphocyte subset values among healthy Cameroonians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

Idiopathic CD4+ T lymphopenia in older persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

CD4 and total lymphocyte counts as predictors of HIV disease progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

The mucosal immune system: primary target for HIV infection and AIDS.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Dynamics of CCR5 expression by CD4(+) T cells in lymphoid tissues during simian immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

1 reference

7 January 2021

Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Factors Influencing Increases in CD4 Cell Counts of HIV‐Positive Persons Receiving Long‐Term Highly Active Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

A prospective study of discontinuing primary and secondary Pneumocystis carinii pneumonia prophylaxis after CD4 cell count increase to > 200 × 106/l

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Clinical indicators of immune restoration following highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Incidence and risk factors for immune reconstitution inflammatory syndrome during highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Immunohematological reference ranges for adults from the Central African Republic

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Low CD4+ T-lymphocyte values in human immunodeficiency virus-negative adults in Botswana

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Human immunodeficiency virus-1 RNA levels and CD4 lymphocyte counts, during treatment for active tuberculosis, in South African patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

CD4 lymphocyte numbers after splenectomy in patients infected with the human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

CD4 T-cell count and HIV-1 infection in adults with uncomplicated malaria

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Coinfection with HTLV-I and HIV: increase in HTLV-I-related outcomes but not accelerated HIV disease progression?

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

CD4 T-lymphocyte subset counts in HIV-seropositive patients during the course of community-acquired pneumonia caused by Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Unexplained opportunistic infections and CD4+ T-lymphocytopenia without HIV infection. An investigation of cases in the United States. The Centers for Disease Control Idiopathic CD4+ T-lymphocytopenia Task Force

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Idiopathic CD4+ T-lymphocytopenia in a non-Hodgkin's lymphoma patient

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Paradoxical CD4+ T-cell decline in HIV-infected patients with complete virus suppression taking tenofovir and didanosine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Diagnostic accuracy of CD4 cell count increase for virologic response after initiating highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV type 1C-infected adults treated with ZDV/ddI-containing HAART in southern Africa

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Evaluation of a low-cost method, the Guava EasyCD4 assay, to enumerate CD4-positive lymphocyte counts in HIV-infected patients in the United States and Uganda

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Successful implementation of a low-cost method for enumerating CD4+ T lymphocytes in resource-limited settings: the ANRS 12-26 study

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Monitoring of human immunodeficiency virus infection in resource-constrained countries

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

An inexpensive, simple, and manual method of CD4 T-cell quantitation in HIV-infected individuals for use in developing countries

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Comparison of a new, affordable flow cytometric method and the manual magnetic bead technique for CD4 T-lymphocyte counting in a northern Nigerian setting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Absolute CD4 T-cell counting in resource-poor settings: direct volumetric measurements versus bead-based clinical flow cytometry instruments.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Comparison of two alternative methods for CD4+ T-cell determination (Coulter manual CD4 count and CyFlow) against standard dual platform flow cytometry in Uganda

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

The Partec CyFlow Counter could provide an option for CD4+ T-cell monitoring in the context of scaling-up antiretroviral treatment at the district level in Malawi

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Validation of primary CD4 gating as an affordable strategy for absolute CD4 counting in Cambodia

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Evaluation of the Partec flow cytometer against the BD FACSCalibur system for monitoring immune responses of human immunodeficiency virus-infected patients in Zimbabwe

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Determination of CD4+ and CD8+ lymphocytes with the cytosphere assay: a comparative study with flow cytometry and the immunoalkaline phosphatase method

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

A rapid manual method for CD4+ T-cell quantitation for use in developing countries

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

The search for a predictor of CD4 cell count continues: total lymphocyte count is not a substitute for CD4 cell count in the management of HIV-infected individuals in a resource-limited setting

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Complete blood cell count as a surrogate CD4 cell marker for HIV monitoring in resource-limited settings

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Discontinuation of Secondary Prophylaxis againstPneumocystis cariniiPneumonia in Patients with HIV Infection Who Have a Response to Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.B.20383

7 January 2021

Identifiers

DOI

10.1002/CYTO.B.20383

1 reference

17 August 2017

1 reference